Proehl Investment Ventures LLC - Aug 17, 2021 Form 4 Insider Report for Dermata Therapeutics, Inc. (DRMA)

Role
10%+ Owner
Signature
/s/ Gerald T. Proehl, Managing Member
Stock symbol
DRMA
Transactions as of
Aug 17, 2021
Transactions value $
$0
Form type
4
Date filed
8/17/2021, 12:48 PM
Previous filing
Aug 12, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction DRMA Common Stock Conversion of derivative security +361K +39.37% 1.28M Aug 17, 2021 Direct F1
transaction DRMA Common Stock Conversion of derivative security +112K +8.76% 1.39M Aug 17, 2021 Direct F2
transaction DRMA Common Stock Conversion of derivative security +182K +13.06% 1.57M Aug 17, 2021 Direct F3
transaction DRMA Common Stock Conversion of derivative security +1.25M +79.38% 2.82M Aug 17, 2021 Direct F4
transaction DRMA Common Stock Conversion of derivative security +85.6K +3.04% 2.91M Aug 17, 2021 Direct F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DRMA Series 1d Preferred Stock Conversion of derivative security $0 -2.44M -100% $0.00 0 Aug 17, 2021 Common Stock 361K Direct F1
transaction DRMA Series 1a Preferred Stock Conversion of derivative security $0 -2.3M -100% $0.00 0 Aug 17, 2021 Common Stock 112K Direct F2
transaction DRMA Series 1b Preferred Stock Conversion of derivative security $0 -3.72M -100% $0.00 0 Aug 17, 2021 Common Stock 182K Direct F3
transaction DRMA Series 1c Preferred Stock Conversion of derivative security $0 -25.6M -100% $0.00 0 Aug 17, 2021 Common Stock 1.25M Direct F4
transaction DRMA Series 1 Preferred Stock Conversion of derivative security $0 -1.76M -100% $0.00 0 Aug 17, 2021 Common Stock 85.6K Direct F5
transaction DRMA Series 1a Warrants Conversion of derivative security $0 -574K -100% $0.00 0 Aug 17, 2021 Common Stock 28K Direct F6
transaction DRMA Warrant to Purchase Common Stock Conversion of derivative security $0 +28K $0.00 28K Aug 17, 2021 Common Stock 28K $20.50 Direct

Explanation of Responses:

Id Content
F1 The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the "IPO"). The Series 1d Preferred Stock was convertible at any time and had no expiration date.
F2 The Series 1a Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1a Preferred Stock was convertible at any time and had no expiration date.
F3 The Series 1b Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1b Preferred Stock was convertible at any time and had no expiration date.
F4 The Series 1c Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1c Preferred Stock was convertible at any time and had no expiration date.
F5 The Series 1 Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1 Preferred Stock was convertible at any time and had no expiration date.
F6 The Series 1a Preferred Warrants converted into warrants to purchase Common Stock in connection with the IPO.